Shay Capital’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
Other funds holding ACHV
PBM
VCM
SAM
NCM
Shay Capital's ACHV Position: Q1 2026 in Review
Shay Capital reduced its Achieve Life Sciences (ACHV) stake by 13% in Q1 2026, selling an estimated $132K and leaving 205,114 shares worth $603K. The position accounts for 0.05% of the portfolio, ranked #238.
Shay Capital first reported a position in ACHV in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.03M in Q2 2023. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.
- Shay Capital held 205,114 shares of Achieve Life Sciences worth $603K as of Q1 2026.
- Shay Capital sold 29,823 Achieve Life Sciences shares in Q1 2026, an estimated $132K.
- Achieve Life Sciences made up 0.05% of Shay Capital's portfolio in Q1 2026, its #238 holding.
- Shay Capital first reported a position in Achieve Life Sciences in Q1 2021 and has held it in 21 quarters since.
- Shay Capital's Achieve Life Sciences position peaked at $4.03M in Q2 2023.
- 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.
Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.